Champions Oncology Inc (CSBR)

Champions Oncology Inc (CSBR) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $66.9M; returns 1 day -0.8%, 1 week +0.4%, 1 year -30.1%.

Champions Oncology Inc is a technology-enabled life sciences company specialized in accelerating oncology drug development through advanced translational research platforms. The company primarily operates through two segments: Translational Oncology Solutions (TOS), which accounts for the vast majority of revenue (approx. 98%), and its emerging Data Business.

Groups CSBR belongs to

CSBR financial model: income statement, cash flow and balance sheet